Skip to main content

. 1972 Mar 18;1(5802):749. doi: 10.1136/bmj.1.5802.749-b

Risk with -blocking in bronchial asthma.

J Gaddie, C Skinner

PMCID: PMC1787674 PMID: 4401337

749

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Connolly C. K., Batten J. C. Comparison of the effect of alprenolol and propranolol on specific airway conductance in asthmatic subjects. Br Med J. 1970 May 30;2(5708):515–516. doi: 10.1136/bmj.2.5708.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
MCNEILL R. S. EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS. Lancet. 1964 Nov 21;2(7369):1101–1102. doi: 10.1016/s0140-6736(64)92617-0. [DOI] [PubMed] [Google Scholar]
Palmer K. N., Hamilton W. F., Lge J. S., Diament M. L. Effect of a selectivebeta-adrenergic blocker in preventing falls in arterial oxygen tension following isoprenaline in asthmatic subjects. Lancet. 1969 Nov 22;2(7630):1092–1094. doi: 10.1016/s0140-6736(69)90701-6. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES